This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Meetings update

Published: 21 Aug 2017
Category: Meetings update
By Niall Hyland

In silico and in vitro methods in modern drug discovery

24–25 April 2017 | Nottingham, UK

At our most recent Focused Meeting, the Society welcomed delegates to the University of Nottingham for a two-day conference organised by the Society’s Drug Discovery, Development and Evaluation Affinity Group co-chairs Professor David Kendall (Pharmnovo AB, UK) and Dr Elizabeth Rosethorne (University of Nottingham, UK). The audience discussed novel in silico and in vitro techniques that are being developed to accurately predict human toxicology as well as human dosage prior to clinical trials which may reduce drug attrition during clinical trials, and speed up the route to registration. Delegates also looked into how in silico modelling can be used to enhance medicinal chemistry, minimise animal usage and foster academic drug discovery.

Speakers from the pharmaceutical industry and academia shaped the educational programme, with Professor Graeme Milligan (University of Glasgow, UK) presenting the JR Vane lecture entitled ‘From in vitro to in vivo: challenges in studying free fatty acid receptor 2 (GPR43)’. The best poster prize was awarded to Mr Simon Brooke (MRC Toxicology Unit, Leicester, UK) for his presentation on ‘Pharmacological evaluation of clozapine n-oxide for its use in the in vivo chemical genetic investigation of M1 muscarinic acetylcholine receptor function’. The meeting was sponsored by Integra and received fantastic feedback on its scientific programme.

8th European Workshop on Cannabinoid Research

31 August–2 September 2017 | London, UK

This three-day meeting focused on the latest developments in cannabinoid research will feature the EPHAR lecture presented by Professor Javier Fernandez Ruiz (Universidad Complutense, Spain) on ‘The current biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies’. We invite academics, researchers, clinicians, early career investigators, postgraduate students as well as those working in the pharmaceutical industry, policy makers, government agencies and members of the media to book their place at the early-bird rate and join us at this Focused Meeting in London.

Pharmacology 2017

11–13 December 2017 | London, UK

Preparations for the Society’s annual flagship meeting are well underway, with registration, abstract and bursary submissions now open. To register visit: www.bps.ac.uk/pharmacology2017

The Society has published the “Programme at a Glance”, which includes details of the meeting’s five symposia tracks:

  • Cardiovascular and Respiratory Pharmacology
  • Neuropharmacology
  • Integrated Systems Pharmacology
  • Molecular and Cellular Pharmacology
  • Toxicology & Drug Discovery, Development and Evaluation

There will also be workshops on the following topics:

  • Engaging with ethical review: strengthening relationships between ethical review bodies and researchers
  • Mind the gap: clinical pharmacology in the NHS and pharmaceutical industry
  • Innovations in Pharmacology Education
  • Creating & fostering a diverse professional network

The Meetings Committee would like to encourage Society members to get involved with chairing sessions and judging posters at Pharmacology 2017. If you are interested, please email meetings@bps.ac.uk.

For further information please visit: www.bps.ac.uk/pharmacology2017.

More from Meetings update

Comments

Blog post currently doesn't have any comments.

If you are a British Pharmacological Society member, please sign in to post comments.

About the author

Niall is Lecturer in Pharmacology in the School of Medicine at University College Cork, Republic of Ireland. He also holds a Faculty position at the APC Microbiome Institute where his research focuses on the microbiotagut-brain axis. Niall has a PhD in Pharmacology from King’s College London and trained in both the USA and Canada. He is Co-chair of the Society’s Systems and Integrative Pharmacology Affinity Group and on the Editorial Board of the British Journal of Pharmacology. He also contributes to the activities of the European Society of Neurogastroenterology and Motility and The American Gastroenterological Association Institute Council.

Susanne joined the British Pharmacological Society from the Royal Society of Medicine, where she had looked after a number of medical specialities and organised clinical and nonclinical meetings and events. Previous to that Susanne lived and worked in Bournemouth and Brussels where she organised educational and pharmaceutical conferences in Europe and North America. She is responsible for the logistical organisation and management of upcoming meetings and events.